Pharma Pulse 7/1/24: How Can Incoming, Existing Executives Build a Sustainable Role?

News
Article

The latest news for pharma industry insiders.

With CEO Turnover Rising to Record Levels, How Can Incoming, Existing Executives Build a Sustainable Role?

A Q&A with Russell Reynolds’ Global Lead of CEO & Executive Transition Practice, Ty Wiggins, PhD.

FDA Approves New Drug Application for Tepylute to Treat Breast, Ovarian Cancer

Tepylute is a ready-to-dilute, injectable formula that reduces preparation time and enable dosing accuracy.

AI Frenzy Propels Stocks to Monster First Half

S&P 500 has climbed 15% despite reduced hopes for Federal Reserve interest-rate cuts.

Global mRNA Cancer Vaccines Clinical Trials & Future Market Outlook 2024 - ResearchAndMarkets.com

The "Global mRNA Cancer Vaccines Clinical Trials & Market Future Outlook 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.

Global mRNA Cancer Vaccines Clinical Trials & Future Market Outlook 2024 Report Highlights:

  • mRNA Cancer Vaccines in Clinical Trials: > 60 Vaccines
  • Highest Phase of Clinical Trials: Phase III (2 Vaccine)
  • mRNA Cancer Vaccine Clinical Trials Insight by Company, Country, Indication & Phase
  • First Commercial mRNA Vaccine Approval Expected by 2029
  • US & China Dominating mRNA Cancer Vaccines Clinical Trials: > 45 Vaccines
  • mRNA Vaccines for Skin Cancer Dominating Trials: > 10 Vaccines

@fda on Threads

Caregivers: Your job can be challenging at times.

Our office of women’s health has resources to help you care for yourself and others:

Have news you want us to share in Pharma Pulse? Reach out to Social

Media Editor Miranda Schmalfuhs

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

© 2025 MJH Life Sciences

All rights reserved.